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Introduction 
Gout probably has been the best 
documented of human diseases 
throughout the ages. This may be 
because it is easily identifiable, 
owing not only to the dramatic 
nature of its sudden painful, acute 
episodes, but also--which may 
have pleased the masses-to its 
tendency to pick out rather impor-
tant and wealthy victims. For the 
underdog, seeing that sort of per-
son suddenly and unpredictably in-
capacitated, with his afflicted foot 
swathed in monstrous protective 
bandages, the disease assumed a 
uniquely comic aspect which has 
persisted to this day, although 
never shared by sufferers from 
what the great Dr. Samuel Johnson 
described as "the most diabolic 
[pain] to which man may be sub-
jected." 
Gout was not a word devised by 
the medical profession, but rather a 
colloquialism used first by the teu-
tonic denizens of the northern out-
posts of the Roman Empire, for 
what the Greeks termed generically 
"arthritis," i.e., disease of the joints. 
When it affected the great toe, as 
true gout frequently does (Fig. 1) , 
they termed it podagra. The term 
was based upon the Latin word 
gutta (a drop) . According to their 
humoral hypothesis , phlegm, one 
of the four constituent humours 
which made up the human body, 
could be distilled in excess and 
would then drop into weakened 
joint cavities, the distension thus 
caused producing the great pain 
and swelling typical of the disease. 
The first person in modern times 
to distinguish between gout and 
2 
rheumatic fever as specific entities 
was the 16th century French 
Royal Physician Guillaume de Bail-
lou, also called Ballonius ( 1642) . 
A little later, the great Thomas 
Sydenham independently made the 
same differentiation in his classic 
and often quoted description, draw-
ing largely upon his own suffer-
ings from the former disease. 
The basic cause of the gout, like 
that of all other disease processes, 
was believed by most physicians of 
the early world to lie in an altera-
tion or an imbalance of the body 
humours (Fig. 2) . A modified view 
is attributed to Aretaeus the Cap-
padocian (fl. A.O. 135) , however, 
who asserted that "the basic cause 
of this disease none but the Gods 
can ever understand." In the 18th 
century, the Age of Reason, gen-
era! medical op1mon was summa-
rised by Dr. Walter Harris, who 
wrote that a man may have a 
"gouty disposition" even when he 
is free of "actual fitts" (diathesis). 
He thought, moreover, that "The 
Common Opinion as to Wine and 
Women is proved unjust and un-
charitable." 
Here the matter rested until Sir 
Alfred Garrod discovered, in 1848, 
that the "morbid circulating mat-
ter" which had always been as-
sumed to be causative of the gouty 
diathesis was uric acid . The hered-
itary and seasonal nature of the 
affliction had been remarked upon 
by Galen (A.O. 120) , the most no-
table disciple of Hippocrates, who, 
in his writings 600 years previously, 
had also noted the association of 
the acute attacks with various 
Fig. I- True gout in the great toes of an ancient Greek. 
M CV QUARTERLY 5(1): 2-8, 1969 
stresses- chiefly those of a bibu-
lous, gastronomic or sexual nature. 
He also pointed out correctly that 
eunuchs and women who had not 
reached the menopause never fell 
victim. The distinguished contempo-
raries of Hippocrates-King Priam 
of Troy, King Oedipus of Thebes 
and the hero Achilles- were all, he 
reported, sufferers from gout. The 
Roman poet Lucian wrote a popu-
lar burlesque tragedy on the pow-
ers of the Goddess Podagra and 
the ineffectiveness of human treat-
ment. Tophaceous deposits were 
noticed and commented upon by 
most of the early medical writers, 
including the second century phy-
sician Soranus of Ephesus, who 
advocated their surgical removal in 
selected cases. It was the great 
English chemist William H . Wol-
laston, F.R.S., who, in the 18th 
century, was able to demonstrate 
that a tophus removed from his 
own ear was composed of uric acid. 
Prognosis 
With regard to the prognosis of 
the disease, Aretaeus rightly pointed 
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Fig. 2-Possibly the earliest p rinted 
work on gout ( 1577 ) . 
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out that, once gout is declared in 
a person, "the disease sticks to him 
until death." Hippocrates stated 
that those affected "who are aged 
and have tophi in their joints and 
those who have led a hard life and 
whose bowels are constipated, are 
beyond the power of medicine to 
cure .. . . Persons under other cir-
cumstances may be cured by a 
skillful physician." He pointed out 
that the younger the sufferer, the 
poorer the outlook. These views 
remained largely unaltered until 
comparatively modern times, when 
uricosuric preparations were intro-
duced and the disease process at 
last became controllable by chem-
ical means. It is interesting to note 
that 50 years ago most insurance 
companies took an extremely un-
favourable view of the prognosis in 
victims of gout, whilst today the 
majority of adult cases are accepted 
at normal rates. In 1959 John H. 
Talbott and Abraham Lilienfeld 
showed that the mortality rate 
among gouty sufferers in the United 
States was similar to that in the 
general population. 
Classification 
Classification remained simple 
until the 18th century, because the 
early Greek writers regarded all 
affections of joints, except those of 
directly traumatic origin, as being 
of the same basic "gouty" nature, 
despite evidence in the surviving 
works of Hippocrates that he may 
have recognised a difference be-
tween the syndromes of true gout 
and rheumatic fever. If Hippoc-
rates did recognise a distinction, 
it was forgotten by his successors 
until the 17th century. Even then, 
Sydenham's views were not univer-
sally accepted, if we may judge 
from his dry remark, "Doubtless 
gout and rheumatism were often 
confounded by the ancient Greek 
physicians; a point which is still 
equally applicable to the great 
pundits of our present day." Until 
that time, the generic term used 
was "arthritis," and its evident 
varieties were merely classified ac-
cording to an anatomical plan : 
podagra, when it afflicted the foot 
(Fig. 3) ; chiagra, the hand; gona-
gra, the knee; and so on, through-
F ig. 3- A personal reminiscence of podagra (1799 ) by James G ill ray. 
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Fig. 4-Sydenham's notebook ; in pos-
session of the Royal College of Phy-
sicians. 
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out the joints of the body, and in-
cluding sciatica. This simple con-
venient authoritarian method of 
classification persisted unchanged 
for the next thousand years, al-
though occasional murmurs of 
doubt could be heard , as when Dr. 
Andrew Boorde, who was one of 
King Henry YUi's physicians, 
warned (1547) that, despite gen-
eral belief, "All jointe illnesses are 
not the goute. " He added in an in-
dependent vein, "It is extremely 
difficult for a physician who puts 
too much trust in what he reads to 
form a proper decision from what 
he sees," a sentiment which we can 
still endorse. 
With the 18th century came the 
fashion started by Carolus Linnaeus, 
the great botanist, for evolving "sys-
tems" of classification. Articular 
affections received considerable at-
Fig. 5- "Comfort in the Gout" (J. Rowlandson, 1785) . 
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tention from leaders of the profes-
sion throughout Europe. Gout then 
became subdivided into 14 varieties 
and species with further subdivi-
sions according to its seasonal var-
iations and its association with 
other disorders. Its visceral mani-
festations also became more gen-
erally known and were classified 
under the headings "Anomalous," 
"Irregular," "Retrocedent" or "Mis-
placed" Gout. Such classifications, 
however, perpetuated the belief 
that gout was the basic prototype 
of all joint affections other than 
those attributable to rheumatic 
fever or Sydenham's further inde-
terminate class of "scorbutic affec-
tions of the joints." It was just over 
a century ago (1859) that Garrod 
(who should be known as the 
"Father of Modern Rheumatol-
ogy" ), as the result of his studies 
in morbid anatomy, was able to 
differentiate between the clinical 
entities of rheumatoid arthritis, for 
which he suggested the name, and 
osteoarthritis. Modern classification 
of joint affections bas become 
complicated once more with the 
identification of an increasing num-
ber of disease processes. The sys-
te m most generally accepted is the 
one proposed by the A.M.A. , which 
seems sufficiently flexible to ac-
commodate further increases in 
knowledge as they occur and in-
cludes the various types of gout 
currently recognised . 
Pathology 
The pathology of gout began to 
arouse interest subsequent to the 
acceptance of Thomas Sydenham's 
reintroduction of sound observa-
tional medicine into England to-
wards the end of the 17th century. 
He clearly and unambiguously 
described the clinical features of 
gout and its associated pathology, 
such as tophus formation ("stony 
concretions like unto chalk") in 
the tissues around joints and in the 
cartilage of nose and ear, leading 
to chronic and sometimes crippling 
conditions-e.g. , urinary stone, 
heart disease and apoplexy (Fig. 
4) . His influence quickly spread 
throughout Europe with the help of 
such distinguished admirers as the 
Dutchman Hermann Boerbaave and 
his pupils William Cullen and Sir 
John Pringle of Edinburgh and, 
later, Gerard Van Swieten and 
Baron Anton Von Stoerk of Vienna. 
Increasing interest in the pathology 
of gout coincided with the develop-
ment of the microscope and the 
general introduction of postmortem 
examination , which, until that time, 
had been discouraged by the 
Church. This conjunction of cir-
cumstances culminated in the first 
great work on morbid anatomy 
(1761) produced by Giovanni Mor-
gagni, the Italian founder of that 
subject. His description of the pa-
t hology of gout was carried further 
by Jean Bichat, the father of 
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French scientific medicine, in bis 
splendid work Anatomie Patholo-
gique of 1825. 
The interesting "mediaeval" char-
acter, Paracelsus, half alchemist-
quack and half genius, was the 
first to suggest that gout might 
not be a product of humoral de-
rangement, but might instead be a 
" tartarous" chemical abnormality ; 
proof was lacking, however. The 
first step towards an accurate met-
abolic conception of the disease 
was taken when the Swedish apoth-
ecary Karl Wilhelm Scheele di s-
covered uric acid (1776) in the 
course of chemical researches 
carried out after business hours in 
the kitchen of bis herb shop. The 
next step was Wollaston's discov-
ery, noted above, that gouty tophi 
contained uric acid . It was this 
knowledge which led to Garrod's 
demonstration ( 1848) that uric 
acid was the eminence grise be-
hind the various manifestations of 
gout. For that purpose, he devised 
bis famous "thread test," one of 
the first bedside chemical tests ever 
used for diagnostic purposes. 
Subsequently, much further light 
was thrown upon the metabolic 
complexities of gouty metabolism 
as the result of the monumental 
work of the German chemist Emil 
Fischer (1852-1919) , who first 
established the relationship of uric 
acid to purine protein bodies. He 
worked out the family tree of gout 
and showed that the purine nucleus 
was the common ancestor of all 
the metabolic products of the dis-
ease. This was the scientific foun-
dation of our present improved 
understanding of the disease pro-
cess, which has been facilitated by 
advances in such important aids as 
micromethods of blood analysis 
and isometric labelling. 
Treatment 
The general plan of treatment 
for gout systematised by the Hip-
pocratic physicians was based upon 
their conception of humoral pa-
thology and varied very little until 
comparatively recent times. Its ob-
jective was to evacuate the offend-
ing matter from the body through 
all available routes by purging, 
sweating, diuresis and bleeding. 
The system would then have to be 
built up by proper diet and exer-
cise so that the humoral defects 
would right themselves and the 
body would act , henceforth, as its 
own physician. With minor and 
fashionable variations, that system 
of management altered but little 
until the middle of the last cen tury 
(Fig. 5) . 
The modem treatment of gout 
depends upon the use of powerful 
anti-inflammatory substances to 
subdue its acute episodes . More 
basically important, however, are 
the long-term measures which must 
also still be used between attacks, 
with the objective of lowering the 
blood level of uric acid and so, in 
time, preventing further attacks. 
Such "interval treatment" may 
have to be maintained almost 
permanently in certain patients by 
means of both medication and 
regime. 
Of the anti-inflammatory sub-
stances used for the former pur-
poses, colcbicine is still probably 
the most specific. Until 1884 this 
alkaloid was obtained from the 
corm of the autumn crocus, Col-
chicum autumnale (Fig. 6). It was 
known by the name of hermodactyl 
to the ancient Greeks, who em-
ployed it as a powerful purgative. 
As purgation was considered by 
them to be the easiest and best 
method of eliminating the "pec-
cant gouty humour," they evidently 
obtained good therapeutic results , 
although there is no convincing evi-
dence that they recognised the spe-
cific effect of hermodactyl upon the 
disease. During the Middle Ages 
polypharmacy became the fashion , 
but small amounts of hermodactyl 
were still used in purgative pre-
scriptions throughout Europe. It 
was Sydenham who eventually de-
cided that purgation was inappro-
priate as a therapeutic measure in 
gout. Such was his influence that 
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the use of substances for catharsis, 
including colchicum, was discon-
tinued for the next 200 years . As 
alternative treatment, dietetic mea-
sures, bleeding, blistering, diuresis 
and sweating, together with mod-
erate physical exercise and a quiet 
routine life, were reverted to with 
some degree of success. The names 
of the English physici ans William 
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Cadogan, George Cheyne and Wil-
liam Heberden were particul arly 
associated with such regimes dur-
ing the 18th century. 
Reintroduction of colchicum for 
the treatment of gout is gener-
ally attributed to Yon Stoerk of 
Vienna ( 1763) . It seems, however, 
that he advocated its use prin-
cipally for the treatment of oedema 
Fig. 6-Colchicum, or the Meadow Saffron. From a French herbal. 
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of cardiac origin ; its value in 
the gout remained forgotten until 
a French quack introduced his 
secret remedy L 'Eau d'Husson 
about 1780. This enjoyed imme-
diate success among the many dis-
tinguished sufferers in Europe. The 
Prince Regent of England , the 
"First Gentleman of Europe," was 
a great sufferer, but his physi-
cians refused to allow him to ob-
tain a supply, as it was a "patent 
medicine of unknown composi-
tion ." Eventually, he used hi s royal 
prerogative, saying, "Gentlemen, I 
have taken your half-measures long 
enough to p lease you. . . . From 
now on I shall take colchicum to 
please myself." As he had pre-
viously been ingesting l ,200 drops 
of laud anum daily without relief of 
pain, the immediate results of the 
beneficial effect of colchicum were 
fe lt indirectly throughout the Con-
tinent. The success of this medica-
ment led to a spate of other sec ret 
remedies such as the famous "Port-
la nd Powder," but none of them 
achieved permanent success. It is a 
curious fac t, however, that al-
though most of the world 's leading 
physicians thereafter adopted the 
use of colchicum , an influential 
minority, which included the cele-
brated Frenchman Armand Trous-
seau, held out aga inst it in th e 
belief that its use would merely 
suppress the acute manifestations 
by driving them into other part s 
of the body, thereby increasi ng the 
underl ying viscera l gravity of the 
disease. 
Other substances of quite recent 
introduction which are used in gout 
for their anti-inflammatory and 
analgesic properties are: a) phenyl -
butazone compounds; b) indometh-
acin ; and c) steroid hormones, 
although these are now seldom 
employed. 
For the long-term control and 
management of gouty arthritis , in 
addition to instituting dietetic re-
gime it was necessary to find sub-
stances capable of lowering the 
level of the uric acid present in the 
sufferer's blood stream . The first 
substance of this type was cincho-
phen (atophan) which was syn-
thesised as early as 1887 in Ger-
many and was introduced into 
clinical medicine for this purpose 
by W. Weintraud of Berlin in 
1911. For a time it served its pur-
pose, but eventually its often dan-
gerous side effects severely limited 
its use. The only alternative was 
sodium salicylate which for this 
purpose, however, had to be giwen 
in a dosage so high that most 
patients were unable to tolerate it 
for long. 
Jt was not until 1948-exactly 
a century after the discovery of 
uric acid as the fons et origo of 
the gouty state- th at a satisfactory 
uricosuric substance was discov-
ered, as a side issue, during the 
course of experiments designed to 
broaden the spectrum of penicillin. 
Jn that year William Q. Wolfson 
and his colleagues noted that cari-
namide, give n in doses of 10-20 
gm, would lower the blood level of 
uric acid whilst increasing total 
urinary excretion. This dosage level 
proved too high for safety, how-
ever, and it was not until its syn-
thetic progeny probenecid was de-
veloped in 195 1 that these results 
could be obtained with comparative 
immunity from side effects. In 
1959 benemid was introduced into 
clinical practise and since then has 
proved to be a safe and effective 
uricos uric agent. Synthetic var-
iants continue to be added to our 
therapeutic armamentarium for in -
ducing a prolonged negative uric 
balance in the body. 
In 1966 a new type of sub-
stance, a ll opurinal, was introduced 
wh ich, by enzyme act ion , is able to 
effectively suppress the synthesis 
of uric ac id in the body and elimi-
nate purines in their intermediate 
synthetic stages of xa nthine and 
hypoxanthine, a process which 
does not appear to be followed by 
unwanted side effects. An impres-
sive secondary result of allopurinal 
administration is the gradual reab-
sorption of fully formed tophi . 
Other methods of treating gout 
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which have had thei r vogue at 
times throughout the ages include 
magic symbolism, use of the lode-
stone (magnetism) , counterirrita-
tion such as produced by burn-
ing fl ax (moxa) or the cautery, 
hypnotism, hydrotherapy and use 
of electric currents. The earliest 
use of electrotherapy was de-
scribed by the Rom an ph ys ician 
Scribonius Largus (A.D . 46), who 
sa id th at, "For any type of gout 
... a live black torpedo fish should 
be placed under the feet. The pa-
tient must stand on a moist shore 
washed by the sea, and he should 
stay like this until his whole leg up 
to the knee is numb .. .. " This 
treatment was later the subject of 
a commentary by G alen. 
Medicinal "specifics" were a 
legitimate part of the stock-in-trade 
of many celebrated physici ans 
in the past for the treatment of a 
number of diseases, including the 
gout. Most of these spec ifics, in-
cluding the "Gout Cordial " advo-
cated by Hermann Boerhaave, the 
"Batavian Hippocrates," contained, 
among other ingredients, white 
hellebore (Vera /rum album.) or 
guaiacum bark. The hosts of itin-
erant quacks and empirics who 
pera mbulated E urope also used 
mineral substances such as anti-
mony, arsenic and mercury which 
could be-and often were- highl y 
dangerous. During the acute phase 
of a gouty attack, opiates would 
naturally be called for by the suf-
ferer , although, strangely, most or-
thod ox medical opinion during the 
17th and 18th centuries frowned on 
the practise, as it was thought that 
the disease would only be tempo-
rarily miti ga ted and would be likely 
to recur thereafter in a more malig-
nant and lastin g guise . The custom 
of hot and cold bathing practised 
by the anci ent Greeks led directly 
to the later development of the 
va rious mineral water spas which 
attracted the wealthier sufferers for 
treatment during the 18th and 19th 
centuries-and still do. To Para-
celsus, who first suggested a chem-
ical origin for the disease. these 
healing springs represented nature 's 
laboratories, revealing to men the 
hidden virtues and powers of the 
vix medicalrix naturae. 
The use of external applications 
was universal during the Middle 
Ages and the Rena issa nce , and 
secret recipes for such unguents 
and plasters, if the ingredients were 
sufficientl y exotic or expensive, 
were often used as gifts by sup-
pliants to ingrati ate monarchs and 
potentates. During the 18th cen-
tury, however, external remedies 
were considered undesirable, as 
they tended to "fix the inflamma-
tion" in the affec ted joints; a policy 
of laissez-fa ire concerning the out-
sid e of the body was considered 
preferable. 
It is interesting to note th at the 
treatment of gout- the best docu-
mented disease of mankind and 
one which, Sydenham remarked , 
" . .. destroys more rich th an poor 
persons, and more wise men than 
fools"-remained basically un-
changed from the earlies t days 
until the first quarter of the last 
century. 
Wine 
From ea rly times it had been 
remarked that the stresses put 
upon metabolism by heavy eating 
or drinking would often culmin ate 
in an episode of go ut. Hippocrates 
and his followers , therefore, pl aced 
great importance upon moderation 
in both food and wine. Curiously, 
he believed that the heav ier , 
sweeter wines of Salerno and the 
South were to be preferred. 
In 1688 the French wines popu-
lar in England began to be fortified 
with brandy as a prese rvative, and 
the incidence of gout markedly 
rose. According to one authority, 
"Burgundy is, of all wines, the 
most certain fuel to the go ut. " In 
1703 gouty Queen Anne of Eng-
land concluded the Trea ty of 
Methuen whereby port wine was 
substituted for the French wines . 
It became very popular, according 
to Richard Mead , "as an antidote 
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to the damp climate and fogs of 
England, the inhabitants being at 
that time unaware of the canker 
that lurks in every glass for the 
gouty subject." From the time of 
the legendary invention of cham-
pagne by a French Benedictine 
monk in 1718, there was almost 
unanimous agreement within the 
Faculty that this wine above all 
others would precipitate attacks of 
gout. The 19th century gave rise 
to considerable learned and pseudo-
learned literature upon the subject. 
In a lighter vein one may quote a 
letter of James Russell Lowell 
from Boston . He wrote: "I call 
my gout the unearned increment 
from my grandfather's madeira, 
and think how excellent it must 
have been-I sip it from the bin 
of fancy , and wish he had left to 
me the cause instead of the effect." 
As Benjamin Franklin pointed out, 
the truth of the matter, if we 
exclude those rare persons who 
have an allergic sensitivity to cer-
tain wines, may have been enun-
ciated by Thomas Sydenham when 
he said ( 1682) , "If you drink wine 
you get the gout ; if you do not 
drink wine-the gout has you." 
Historic Effects 
Reference was made earlier to 
the effect that gout appears to have 
exercised upon world affairs. Sev-
eral of the great Renaissance Italian 
Medici rulers who were sufferers 
serve to illustrate the association 
between outstanding ability and 
gouty diathesi s which has been re-
marked upon throughout the ages. 
Of "Piero ii Grottoso" (Peter the 
Gouty) it was written that his dis-
ease "caused him often to leave the 
affairs of his state to others less 
worthy." The great Holy Roman 
Emperor Charles V, who suffered 
his first attack at the age of 28, 
eventually was forced to the un-
precedented step of abdicating in 
favour of hi s son Philip II of Spain, 
who married Mary Tudor, Queen 
of England, and , in turn, died 
crippled of the same complaint. 
8 
THE STORY OF GOUT 
Had not the great Lord Burghley, 
Chancellor of England, himself 
been incapacitated with an attack 
of the same disease, he would have 
been able to prevent that marriage 
which brought such misfortune to 
his country. 
The well-known 17th century 
statesman Sir William Temple 
pointed out that the gout often 
affected the outlook and policy 
of rulers, saying, "I have seen the 
councils of a very great country 
(France) grow bold or timorous 
according to the fits of gout on its 
Governor. " A final example, nearer 
home, may be of interest. It con-
cerns the English Prime Minister, 
William Pitt, First Earl of Cha-
tham, who by 1763 had concluded 
successfully the seven years' strug-
gle with France for the sovereignty 
of the New World. The cost of 
such victory was high, and it was 
thought that the Colonies should 
share it. So, taking advantage of 
Pitt's absence during an attack of 
gout, Parliament passed the Stamp 
Act, which threw much of the ex-
pense upon the American Colonies 
-without their consent, however. 
On his return Pitt indignantly had 
it repealed, but during a further at-
tack of gout his colleagues sub-
stituted a heavy colonial duty on 
tea to raise the revenue required. 
This culminated in the famous 
Boston Tea Party with its well-
known results . Pitt was abetted in 
his peaceful efforts by his gouty 
American friend and colleague 
Benjamin Franklin, who was said 
to have introduced the first corms 
of colchicum into the colonies on 
his return to Philadelphia, where 
he wrote his well-known and amus-
ing Dialogue between Benjamin 
Franklin and the Gout. It is in-
teresting to speculate on the rela-
tionship our two great countries 
would be enjoying had the redis-
covery of colchicum for the treat-
ment of gout been advanced by 25 
years and the War of Independence 
therefore not taken plaE:e! 
It ·had long been suspected that 
gout might be a disease of varying 
origins, but it has only been during 
the present century that primary or 
acquired gout and hereditary gout 
have been clearly defined and dif-
ferentiated. A considerable number 
of secondary types are now recog-
nised. Several are of iatrogenic 
nature, whereas others result from 
disorders of the blood , the bone 
marrow and the metabolism, as well 
as from associated specific defects 
such as those in the Lesch-Nyhan 
Syndrome of children. Increasing 
knowledge of gout's chemical se-
crets, however, is resulting in im-
proved treatment, and we can now 
assert that gout is perhaps the 
disease of which we have the most 
detailed specific understanding and 
the most effective control. With 
cooperation from the sufferer and 
a mild dietary regime, we can now 
prevent any damage which has al-
ready occurred from progressing 
and, thus, avoid recurrent or pro-
gressive deterioration. In almost 
every case we can now terminate 
the occurrence of the painful 
acute attacks by use of modern 
chemotherapy. 
